Sign in
4

Changes in Ownership

Bicara Therapeutics Inc. Filed Acc 0001470831-26-000814

Chief Financial Officer sold 12,500 shares at $27.97 ($349,591)

  • Chief Financial Officer acquired 12,500 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Hyep Ivan · Chief Financial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-08-10 Exercise or conversion : show line 1 in the form 10b5-1 +12,500 $3.79 $47,373 142,355 D
2026-08-10 Sale : show line 2 in the form 10b5-1 −12,500 $27.97 $349,591 129,855 D
Open-market sales · 12,500 sh · avg $27.97 · $349,591

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-08-10 Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (Right to Buy) −12,500 26,336 D
Loading xslF345X06/wk-form4_1786565959.xml…